Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?

Friday, Hepion Pharmaceuticals Inc. HEPA said it has begun winding down activities in its ASCEND-NASH Trial while continuing to explore strategic…

Related Keywords

,Hepion Pharmaceuticals Inc ,Hepion Pharmaceuticals ,News ,Ggregator ,Reaking News ,Uration ,Media ,